|
Untitled Document
|
| Not a member yet? Register
for full benefits! |
|
|
|
|
|
|
Vagal Electrical Nerve Stimulation Helps With Weight Loss in Clinical Trial
This story is from the category Augmenting Organics
Date posted: 14/01/2009
EnteroMedics Inc., developer of medical devices using neuroblocking technology to treat obesity, and other gastrointestinal disorders, has announced results from its clinical trials of a prosthetic implant designed to block part of the vagal nerve pathways.
The study includes 38 implanted subjects and is designed to evaluate the system's safety and efficacy. Follow-up data show excess weight loss, or EWL, of 37.6% in 9 patients at 18 months of VBLOC Therapy, 28.1% in 17 patients at 12 months of therapy and 17.9% in 35 patients at six months of therapy. To date, no deaths or unanticipated adverse device events have been reported.
See the full Story via external site: ir.enteromedics.com
Most recent stories in this category (Augmenting Organics):
03/03/2017: Adjustable Smart Desks join the Internet of Things
08/02/2017: More screen time for kids isn’t all that bad
24/01/2017: Australia plans automated biometric border control
12/01/2017: Lending a hand: Student 3D prints functional, affordable prosthetic
16/11/2016: Tiny electronic device can monitor heart, recognize speech
02/04/2015: Researchers Build Non-Invasive Brain-Machine Interface to Control Prosthetic Hand
05/02/2015: Researchers at Shanghai University create tri-layered artificial blood vessels for the first time
05/01/2015: Researchers explore the power of mental visualization in maintaining real-life muscle
|
|
